These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17334410)

  • 1. FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2.
    Hattori S; Dhar DK; Hara N; Tonomoto Y; Onoda T; Ono T; Yamanoi A; Tachibana M; Tsuchiya M; Nagasue N
    Lab Invest; 2007 Jun; 87(6):591-601. PubMed ID: 17334410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver.
    Kobayashi M; Takeyoshi I; Yoshinari D; Matsumoto K; Morishita Y
    Surgery; 2002 Mar; 131(3):344-9. PubMed ID: 11894041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of interferon-α on rat liver fibrosis induced by CCl(4)].
    Li Y; Yang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):243-8. PubMed ID: 21464546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis.
    Murata T; Arii S; Mori A; Imamura M
    J Surg Res; 2003 Sep; 114(1):64-71. PubMed ID: 13678700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropoelastin expression is up-regulated during activation of hepatic stellate cells and in the livers of CCl(4)-cirrhotic rats.
    Kanta J; Dooley S; Delvoux B; Breuer S; D'Amico T; Gressner AM
    Liver; 2002 Jun; 22(3):220-7. PubMed ID: 12100572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation.
    Dong MX; Jia Y; Zhang YB; Li CC; Geng YT; Zhou L; Li XY; Liu JC; Niu YC
    World J Gastroenterol; 2009 Oct; 15(38):4753-62. PubMed ID: 19824107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
    Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
    World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel synthetic oleanolic acid derivative (CPU-II2) attenuates liver fibrosis in mice through regulating the function of hepatic stellate cells.
    Wu LM; Wu XX; Sun Y; Kong XW; Zhang YH; Xu Q
    J Biomed Sci; 2008 Mar; 15(2):251-9. PubMed ID: 17922224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide Accelerates the Degradation of Extracellular Matrix in Rat Hepatic Cirrhosis via Down-Regulation of Transforming Growth Factor-β1.
    Lv P; Meng Q; Liu J; Wang C
    Yonsei Med J; 2015 Nov; 56(6):1572-81. PubMed ID: 26446639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury.
    Ohashi N; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Miyamoto T; Nakano A; Sasayama S
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2521-6. PubMed ID: 11116047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.
    Tu CT; Guo JS; Wang M; Wang JY
    J Gastroenterol Hepatol; 2007 Jun; 22(6):877-84. PubMed ID: 17565644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
    Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC
    J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.
    Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y
    Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells.
    Schnabl B; Bradham CA; Bennett BL; Manning AM; Stefanovic B; Brenner DA
    Hepatology; 2001 Nov; 34(5):953-63. PubMed ID: 11679966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells.
    Cao Q; Mak KM; Lieber CS
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1051-61. PubMed ID: 12381518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis.
    Matsuoka H; Arai T; Mori M; Goya S; Kida H; Morishita H; Fujiwara H; Tachibana I; Osaki T; Hayashi S
    Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L103-12. PubMed ID: 12060566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver.
    Fang HL; Lai JT; Lin WC
    Clin Nutr; 2008 Dec; 27(6):900-7. PubMed ID: 18824281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of celecoxib on experimental liver fibrosis in rat.
    Hui AY; Leung WK; Chan HL; Chan FK; Go MY; Chan KK; Tang BD; Chu ES; Sung JJ
    Liver Int; 2006 Feb; 26(1):125-36. PubMed ID: 16420518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
    Giannone FA; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P
    Lab Invest; 2012 Mar; 92(3):384-95. PubMed ID: 22184091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.